200 related articles for article (PubMed ID: 11762358)
1. Ectopic ACTH syndrome: molecular bases and clinical heterogeneity.
Terzolo M; Reimondo G; Alì A; Bovio S; Daffara F; Paccotti P; Angeli A
Ann Oncol; 2001; 12 Suppl 2():S83-7. PubMed ID: 11762358
[TBL] [Abstract][Full Text] [Related]
2. [The ectopic ACTH syndrome].
Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
[TBL] [Abstract][Full Text] [Related]
3. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
Suda T
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Page-Wilson G; Freda PU; Jacobs TP; Khandji AG; Bruce JN; Foo ST; Meece K; White A; Wardlaw SL
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1838-45. PubMed ID: 25013995
[TBL] [Abstract][Full Text] [Related]
6. Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion.
Pelte MF; Schwaller J; Cerrato C; Meier CA
Breast J; 2004; 10(4):350-4. PubMed ID: 15239795
[TBL] [Abstract][Full Text] [Related]
7. A case of ectopic ACTH syndrome due to DDAVP-sensitive but V1b receptor-negative bronchial typical carcinoid with lymphatic metastasis and plasma ProGRP elevation.
Yamamuro T; Inoue K; Nagai Y; Azuma D; Yamamoto A; Hara K; Kohara M; Iwata T; Nakatsuka S; Morii E; Yamamoto T
Endocr J; 2018 Dec; 65(12):1161-1169. PubMed ID: 30232300
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
de Bruin C; Hofland LJ; Nieman LK; van Koetsveld PM; Waaijers AM; Sprij-Mooij DM; van Essen M; Lamberts SW; de Herder WW; Feelders RA
J Clin Endocrinol Metab; 2012 Feb; 97(2):455-62. PubMed ID: 22090282
[TBL] [Abstract][Full Text] [Related]
10. The cellular and molecular basis of the ectopic ACTH syndrome.
White A; Clark AJ
Clin Endocrinol (Oxf); 1993 Aug; 39(2):131-41. PubMed ID: 8396510
[TBL] [Abstract][Full Text] [Related]
11. Ectopic ACTH syndrome caused by pulmonary carcinoid tumourlets.
Povedano ST; Pastor CV; Seoane CP; Reina LJ; Moreno MA; Ortega RP; López-Rubio F; López PB
Clin Endocrinol (Oxf); 2001 Jun; 54(6):839-42. PubMed ID: 11422121
[TBL] [Abstract][Full Text] [Related]
12. ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.
Sathyakumar S; Paul TV; Asha HS; Gnanamuthu BR; Paul MJ; Abraham DT; Rajaratnam S; Thomas N
Endocr Pract; 2017 Aug; 23(8):907-914. PubMed ID: 28614007
[TBL] [Abstract][Full Text] [Related]
13. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor.
Malchoff CD; Orth DN; Abboud C; Carney JA; Pairolero PC; Carey RM
Am J Med; 1988 Apr; 84(4):760-4. PubMed ID: 2840823
[TBL] [Abstract][Full Text] [Related]
14. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.
Pascual-Le Tallec L; Dulmet E; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 2002 Nov; 87(11):5015-22. PubMed ID: 12414866
[TBL] [Abstract][Full Text] [Related]
15. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical study of 18 tumours causing ectopic Cushing's syndrome.
Coates PJ; Doniach I; Howlett TA; Rees LH; Besser GM
J Clin Pathol; 1986 Sep; 39(9):955-60. PubMed ID: 3020095
[TBL] [Abstract][Full Text] [Related]
17. In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression.
Machado MC; Sá SV; Goldbaum TS; Catania M; Campos VC; Corrêa-Giannella ML; Giannella-Neto D; Salgado LR
J Endocrinol Invest; 2007 Apr; 30(4):334-40. PubMed ID: 17556872
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic Cushing's syndrome, a real diagnostic and therapeutic challenge: A case report and literature review].
Meftah A; Moumen A; Massine El Hammoumi M; Hajhouji S; El Jadi H; Anas Guerboub A; Elmoussaoui S; Mayaudon H; Hassane Kabiri E; Hakkou K; Belmejdoub G
Rev Med Interne; 2015 Dec; 36(12):843-7. PubMed ID: 25613810
[TBL] [Abstract][Full Text] [Related]
19. ACTH and CRF-producing bronchial carcinoid associated with Cushing's syndrome.
Zárate A; Kovacs K; Flores M; Morán C; Félix I
Clin Endocrinol (Oxf); 1986 May; 24(5):523-9. PubMed ID: 3024867
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression and modification of silencing mediator of retinoic acid and thyroid hormone receptors involved in the pathogenesis of tumoral cortisol resistance.
Jiang J; Li N; Wang X; Lu Y; Bi Y; Wang W; Li X; Ning G
Endocrinology; 2010 Aug; 151(8):3697-705. PubMed ID: 20555024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
